Minneslate Logo

SF2372 (Legislative Session 94 (2025-2026))

Medical cannabis and cannabis provisions modification

Related bill: HF1877

AI Generated Summary

Purpose of the Bill

The bill aims to amend existing Minnesota statutes related to medical cannabis and cannabis use, focusing specifically on the medical cannabis registry program, production, and regulations. It establishes new guidelines, modifies existing definitions, and shifts certain responsibilities from the Department of Health to the newly created Office of Cannabis Management.

Main Provisions

  • Medical Cannabis Registry Program: The bill defines roles and responsibilities for healthcare practitioners, manufacturers, and the Office of Cannabis Management regarding medical cannabis usage and management.
  • Manufacturer Regulations: It mandates the registration and regulation of medical cannabis manufacturers, including security and testing requirements, transportation, and operational reporting procedures.
  • Data Privacy and Reporting: The bill prescribes privacy measures for patient data and reporting requirements for manufacturers and healthcare practitioners involved in the program.
  • Regulatory Authority: Various powers and duties related to cannabis management are transferred from the Department of Health to the Office of Cannabis Management, establishing it as the body overseeing the cannabis program.
  • Licensing and Compliance: It establishes guidelines for licensing, including criteria for denial, renewal, and inspection processes for cannabis-related businesses, with an emphasis on social equity applicants.
  • Criminal and Civil Protections: Provides legal protections to participants in the cannabis program, preventing penalties from professional boards and ensuring data protection.
  • Changes to Cannabis Definitions and Testing: Updates definitions of cannabis-related terms, amends testing protocols, and outlines product labeling requirements to ensure consumer safety and consistency.

Significant Changes

  • Transfer of Responsibilities: Powers previously held by the Department of Health are now given to an Office of Cannabis Management, which will oversee medical cannabis programs and compliance.
  • Increased Regulation and Compliance Checks: There are stricter requirements for manufacturer operations, including detailed annual audits and the ability for state authorities to conduct unannounced inspections.
  • Inclusion of Social Equity: Certain licenses are initially limited to social equity applicants to promote fair opportunity within the cannabis industry.
  • Product Labeling and Consumer Protection: New labeling standards for cannabis products and hemp edibles to ensure consumer safety, including details on chemical contents and health warnings.

Relevant Terms

  • Medical cannabis
  • Office of Cannabis Management
  • Data privacy
  • Social equity applicant
  • Cannabis microbusiness
  • Compliance and inspection
  • Cannabis product labeling
  • Registry program

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
March 09, 2025SenateFloorActionIntroduction and first reading
March 09, 2025SenateFloorActionReferred toCommerce and Consumer Protection

Citations

 
[
  {
    "analysis": {
      "added": [
        "Clarifying language for health care practitioners.",
        "Definitions for patient registry number and registry verification."
      ],
      "removed": [
        "Definition of 'Commissioner' as it pertains to the section."
      ],
      "summary": "This bill modifies the definition of various terms related to medical cannabis under section 152.22.",
      "modified": [
        "Changes to terms related to medical cannabis manufacturers and the patient registry."
      ]
    },
    "citation": "152.22"
  },
  {
    "analysis": {
      "added": [
        "Requirements for contracting with an independent laboratory to test medical cannabis."
      ],
      "removed": [],
      "summary": "Amendment to the operational requirements for medical cannabis manufacturers.",
      "modified": [
        "Changes to transportation requirements of medical cannabis."
      ]
    },
    "citation": "152.29"
  },
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "Provisions regarding data practices related to medical cannabis are updated.",
      "modified": [
        "Clarifications on data sharing and privacy requirements."
      ]
    },
    "citation": "152.31"
  },
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "Referenced regarding the rulemaking authority related to medical cannabis.",
      "modified": [
        "Expedited rulemaking process parameters."
      ]
    },
    "citation": "14.386"
  },
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "Amendment references definitions related to data practices, including private and nonpublic data.",
      "modified": [
        "Clarifies how data on individuals involved with medical cannabis is managed."
      ]
    },
    "citation": "13.02"
  },
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "Details regulations affecting pharmacists in relation to medical cannabis under section 151.",
      "modified": [
        "Professional responsibilities of pharmacists interacting with medical cannabis."
      ]
    },
    "citation": "151"
  }
]

Sponsors